Type 2 Inflammation Video Library
Clinical Pearls
12/01/2025
Jeffrey M. Cohen, MD
Unlock the clinical relevance of type 2 inflammation beyond atopic dermatitis. Dr Jeffrey Cohen explores cytokine pathways, JAK-STAT signaling, and pivotal dupilumab trials for prurigo nodularis, chronic spontaneous urticaria, and bullous...
Unlock the clinical relevance of type 2 inflammation beyond atopic dermatitis. Dr Jeffrey Cohen explores cytokine pathways, JAK-STAT signaling, and pivotal dupilumab trials for prurigo nodularis, chronic spontaneous urticaria, and bullous...
Unlock the clinical relevance of...
12/01/2025
The Derm APP
Rapid Refresh
10/15/2025
Mona Shahriari, MD, FAAD
Dr Mona Shahriari explains how type 2 inflammation drives atopic dermatitis flares, the role of key cytokines like IL-4 and IL-13, and how emerging treatments target this complex immune cascade.
Dr Mona Shahriari explains how type 2 inflammation drives atopic dermatitis flares, the role of key cytokines like IL-4 and IL-13, and how emerging treatments target this complex immune cascade.
Dr Mona Shahriari explains how...
10/15/2025
The Derm APP
Clinical Pearls
09/15/2025
Kimberly Kincaid McPeeks, MPAS, PA-C
NCCPA-certified physician assistant Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
NCCPA-certified physician assistant Kimberly McPeaks explores key differences between irritant and allergic contact dermatitis. Learn when to use patch testing, and get tips on patient education and management.
NCCPA-certified physician...
09/15/2025
The Derm APP
Rapid Refresh
08/15/2025
Vivian Shi, MD
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the burden of head and neck eczema, common triggers, and key diagnostic clues to distinguish atopic dermatitis from its mimickers.
Dr Vivian Shi explores the...
08/15/2025
The Derm APP
Rapid Refresh
07/15/2025
Daniel C. Butler, MD
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the role of Th2 immunity in dermatology. Learn about Th2-mediated skin diseases like atopic dermatitis and chronic spontaneous urticaria, cutting-edge biologics, JAK inhibitors, and best practices for patient...
Dr Daniel Butler explores the...
07/15/2025
The Derm APP
Rapid Refresh
06/15/2025
Lakshi Aldredge, NP
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge explores type 2 inflammation, its role in atopic dermatitis and prurigo nodularis, and how IL-4, IL-13, and IL-31-targeted therapies restore immune balance and improve patient outcomes.
Dermatology NP Lakshee Aldridge...
06/15/2025
The Derm APP
Clinical Pearls
05/15/2025
Steven R. Feldman, MD, PhD
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical treatments is a major barrier in managing atopic dermatitis.
Poor adherence to topical...
05/15/2025
The Derm APP
Clinical Pearls
04/15/2025
Lauren McGrath
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments for type 2 inflammation in atopic dermatitis, including lebrikizumab, nemolizumab, upadacitinib, and dupilumab.
Explore new systemic treatments...
04/15/2025
The Derm APP
Clinical Pearls
03/15/2025
Lauren McGrath
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical therapies for type 2 inflammation in atopic dermatitis, including tapinarof, roflumilast, and ruxolitinib creams.
Explore the latest topical...
03/15/2025
The Derm APP
Clinical Pearls
02/12/2025
Peter Lio, MD, FAAD
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link between environmental factors, such as pollution and lifestyle changes, and the rise of atopic dermatitis and type 2 inflammation.
Dr Peter Lio explores the link...
02/12/2025
The Derm APP
